Alambatang, Ralph H.
HRN: 06-40-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/02/2024
03/08/2024
IV
1500mg
Every 8 Hours
To Consider Lower Respiratory Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes